Table 1.
Items | |
---|---|
Age/year (mean ± SD) | 56.7 ± 8.8 |
Sex | |
• Male | 44 (83.0%) |
• Female | 9 (17.0%) |
Smoking status | |
• Smoker | 39 (73.6%) |
• Non-smoker | 14 (26.4%) |
Smoking pack/year (mean ± SD) | 22.7 ± 20.0 |
History of chronic lung diseases | |
• No | 19 (35.8%) |
• COPD | 28 (52.8%) |
• DPLD | 6 (11.3%) |
Presenting symptomsa | |
• Cough | 43 (81.1%) |
• Chest pain | 42 (79.2%) |
• Dyspnoea | 27 (50.9%) |
• Haemoptysis | 24 (45.3%) |
• Fever | 21 (39.6%) |
• Hoarseness of voice | 9 (15.0%) |
Chest radiography findingsa | |
• Hilar LN enlargement | 14 (30.4%) |
• Mass | 35 (76.1%) |
• Mass necrosis | 4 (11.4%) |
• Consolidations | 7 (15.2%) |
• Collapse | 2 (4.3%) |
• Pleural effusion | 14 (30.4%) |
• Elevated dome of the diaphragm | 1 (2.2%) |
Platelets count | 368.0 ± 9.0 |
INR | 0.84 ± 0.02 |
Histopathological types | |
• Squamous cell carcinoma | 16 (30.2%) |
• Adenocarcinoma | 16 (30.2%) |
• Large cell carcinoma | 15 (28.3%) |
• SCLC | 6 (11.3 %) |
SD: standard deviation, COPD: chronic obstructive pulmonary disease, DPLD: diffuse parenchymal lung diseases.
Percentages add to more than 100% due to multiple presentation of symptoms or CXR findings. INR: international normalization ratio; LN: lymph node; SCLC: small cell lung cancer.